Loss of Tumorigenicity and Metastatic Potential in Carcinoma Cells Expressing the Extracellular Domain of the Type 1 Insulin-Like Growth Factor Receptor

Cancer Research - United States
doi 10.1158/0008-5472.can-03-3780
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

How Ligand Binds to the Type 1 Insulin-Like Growth Factor Receptor

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Disruption of the Insulin-Like Growth Factor Type 1 Receptor in Osteoblasts Enhances Insulin Signaling and Action

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

All-Atom Structural Models of the Transmembrane Domains of Insulin Receptor and Type-1 Insulin-Like Growth Factor Receptor

Biophysical Journal
Biophysics
2016English

Type 1 Insulin-Like Growth Factor Receptor Targeted Therapies in Pediatric Cancer

Frontiers in Oncology
Cancer ResearchOncology
2013English

P065 Insulin-Like Growth Factor 1 Receptor Regulates the Phenotype and Function of CD21+ B Cells

2018English

The Three Dimensional Structure of the Type I Insulin-Like Growth Factor Receptor

Molecular Pathology
2001English

Loss of Transforming Growth Factor-Beta Type II Receptor Promotes Metastatic Head-And-Neck Squamous Cell Carcinoma

Genes and Development
GeneticsDevelopmental Biology
2006English

Tyrosine Kinases Expressed in Vivo by Human Prostate Cancer Bone Marrow Metastases and Loss of the Type 1 Insulin-Like Growth Factor Receptor

American Journal of Pathology
Forensic MedicinePathology
1999English

Validation of the Type 1 Insulin-Like Growth Factor Receptor as a Therapeutic Target in Renal Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy